Skip to main content

Advertisement

Log in

Diabetes Complications in Racial and Ethnic Minority Populations in the USA

  • Diabetes Epidemiology (S Albrecht, Section Editor)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Racial and ethnic minority populations have a higher burden of diabetes-related complications. There have been many epidemiologic studies to better define these racial/ethnic disparities in diabetes outcomes with additional studies offering interventions to mitigate them. This narrative review highlights the epidemiologic trends in diabetes complications specific to racial and ethnic minorities and underscores differences in microvascular and macrovascular complications of diabetes, health care utilization, and diabetes prevention efforts and also reviews interventions aimed to reduce racial/ethnic disparities and their limitations.

Recent Findings

While we have seen in general an overall improvement in complication rates for all people with diabetes, the disparities between Black and Hispanic compared to non-Hispanic White people with diabetes seem to persist.

Summary

There is a continued need to better understand the underlying causes of and strategies to mitigate race/ethnicity disparities in diabetes complications in the USA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2020.

  2. Hamman RF, Bell RA, Dabelea D, D'Agostino RB Jr, Dolan L, Imperatore G, et al. The SEARCH for Diabetes in Youth study: rationale, findings, and future directions. Diabetes Care. 2014;37(12):3336–44.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Canedo JR, Miller ST, Schlundt D, Fadden MK, Sanderson M. Racial/ethnic disparities in diabetes quality of care: the role of healthcare access and socioeconomic status. J Racial Ethn Health Disparities. 2018;5(1):7–14 Diabetes related quality of care indicators are lower for Hispanics and Blacks compared to Whites. Insurance coverage and education explained some racial and ethnic disparities in diabetes quality of care measures, but not for all, including disparities in HbA1c testing.

    Article  PubMed  Google Scholar 

  4. Osborn CY, de Groot M, Wagner JA. Racial and ethnic disparities in diabetes complications in the northeastern United States: the role of socioeconomic status. J Natl Med Assoc. 2013;105(1):51–8.

    PubMed  PubMed Central  Google Scholar 

  5. Meng YY, Diamant A, Jones J, Lin W, Chen X, Wu SH, et al. Racial and ethnic disparities in diabetes care and impact of vendor-based disease management programs. Diabetes Care. 2016;39(5):743–9.

    Article  CAS  PubMed  Google Scholar 

  6. Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med. 2014;370(16):1514–23 This study shows empidemiological trends in diabetes-related complications signficantly decliend in the past two decades but the burden is still high due to the increasing prevalence of diabetes.

    Article  CAS  PubMed  Google Scholar 

  7. Fong DS, Aiello LP, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care. 2004;27(10):2540–53.

    Article  PubMed  Google Scholar 

  8. Hendrick AM, Gibson MV, Kulshreshtha A. Diabetic retinopathy. Prim Care. 2015;42(3):451–64.

    Article  PubMed  Google Scholar 

  9. Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304(6):649–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Owsley C, McGwin G Jr, Lee DJ, Lam BL, Friedman DS, Gower EW, et al. Diabetes eye screening in urban settings serving minority populations: detection of diabetic retinopathy and other ocular findings using telemedicine. JAMA Ophthalmol. 2015;133(2):174–81.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA. 2016;316(6):602–10.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002;287(19):2519–27.

    Article  PubMed  Google Scholar 

  14. Goldberg JB, Goodney PP, Cronenwett JL, Baker F. The effect of risk and race on lower extremity amputations among Medicare diabetic patients. J Vasc Surg. 2012;56(6):1663–8.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Tan TW, Shih CD, Concha-Moore KC, Diri MM, Hu B, Marrero D, et al. Disparities in outcomes of patients admitted with diabetic foot infections. PLoS One. 2019;14(2):e0211481.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Freeman HP, Payne R. Racial injustice in health care. N Engl J Med. 2000;342(14):1045–7.

    Article  CAS  PubMed  Google Scholar 

  17. American Diabetes Association. 10. Cardiovascular disease and risk management: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2020;43:S111–S34.

    Article  Google Scholar 

  18. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.

    Article  PubMed  Google Scholar 

  19. Writing Group M, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133(4):e38–360.

    Google Scholar 

  20. Casagrande SS, Aviles-Santa L, Corsino L, Daviglus ML, Gallo LC, Espinoza Giacinto RA, et al. Hemoglobin A1c, blood pressure, and Ldl-cholesterol control among Hispanic/Latino adults with diabetes: results from the Hispanic community health study/study of Latinos (Hchs/Sol). Endocr Pract. 2017;23(10):1232–53.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Wong ND, Zhao Y, Patel R, Patao C, Malik S, Bertoni AG, et al. Cardiovascular risk factor targets and cardiovascular disease event risk in diabetes: a pooling project of the atherosclerosis risk in communities study, multi-ethnic study of atherosclerosis, and Jackson heart study. Diabetes Care. 2016;39(5):668–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Stark Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care. 2013;36(8):2271–9.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Lewis EF, Claggett B, Parfrey PS, Burdmann EA, McMurray JJ, Solomon SD, et al. Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus. Am Heart J. 2015;170(2):322–9.

    Article  PubMed  Google Scholar 

  24. Bell CN, Thorpe RJ Jr, Bowie JV, LaVeist TA. Race disparities in cardiovascular disease risk factors within socioeconomic status strata. Ann Epidemiol. 2018;28(3):147–152. https://doi.org/10.1016/j.annepidem.2017.12.007.

  25. Karter AJ, Laiteerapong N, Chin MH, Moffet HH, Parker MM, Sudore R, et al. Ethnic differences in geriatric conditions and diabetes complications among older, insured adults with diabetes: the diabetes and aging study. J Aging Health. 2015;27(5):894–918.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Desai JR, Vazquez-Benitez G, Xu Z, Schroeder EB, Karter AJ, Steiner JF, et al. Who must we target now to minimize future cardiovascular events and total mortality?: lessons from the Surveillance, Prevention and Management of Diabetes Mellitus (SUPREME-DM) Cohort Study. Circ Cardiovasc Qual Outcomes. 2015;8(5):508–16.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Burrows NR, Li Y, Gregg EW, Geiss LS. Declining rates of hospitalization for selected cardiovascular disease conditions among adults aged >/=35 years with diagnosed diabetes, U.S., 1998-2014. Diabetes Care. 2018;41(2):293–302.

    Article  PubMed  Google Scholar 

  28. Shaw PM, Chandra V, Escobar GA, Robbins N, Rowe V, Macsata R. Controversies and evidence for cardiovascular disease in the diverse Hispanic population. J Vasc Surg. 2018;67(3):960–9.

    Article  PubMed  Google Scholar 

  29. Menke A, Casagrande S, Cowie CC. Cardiometabolic health in Asians with diabetes in the US. Diabetes Res Clin Pract. 2017;133:13–9.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Cheng YJ, Imperatore G, Geiss LS, Saydah SH, Albright AL, Ali MK, et al. Trends and disparities in cardiovascular mortality among U.S. adults with and without self-reported diabetes, 1988–2015. Diabetes Care. 2018;41(11):2306–15 Major cardiovascular mortality in adults with DM declined, especially in ischemic heart disease and stroke mortality, but significant gaps remianed across racial and education groups.

    Article  PubMed  Google Scholar 

  31. Kim O, Ovbiagele B, Valle N, Markovic D, Towfighi A. Race-ethnic disparities in cardiometabolic risk profiles among stroke survivors with undiagnosed diabetes and prediabetes in the United States. J Stroke Cerebrovasc Dis. 2017;26(12):2727–33.

    Article  PubMed  Google Scholar 

  32. Rodriguez F, Blum MR, Falasinnu T, Hastings KG, Hu J, Cullen MR, et al. Diabetes-attributable mortality in the United States from 2003 to 2016 using a multiple-cause-of-death approach. Diabetes Res Clin Pract. 2019;148:169–78.

    Article  PubMed  Google Scholar 

  33. Shah NS, Lloyd-Jones DM, O'Flaherty M, Capewell S, Kershaw KN, Carnethon M, et al. Trends in cardiometabolic mortality in the United States, 1999-2017. JAMA. 2019;322(8):780–2.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Villarroel MA, Vahratian A, Ward BW. Health care utilization among U.S. adults with diagnosed diabetes, 2013. Hyattsville, MD: National Center for Health Statistics; 2015. Contract No.: 183.

  35. Wetterhall SF, Olson DR, DeStefano F, Stevenson JM, Ford ES, German RR, et al. Trends in diabetes and diabetic complications, 1980-1987. Diabetes Care. 1992;15(8):960–7.

    Article  CAS  PubMed  Google Scholar 

  36. Bazargan M, Johnson KH, Stein JA. Emergency department utilization among Hispanic and African-American under-served patients with type 2 diabetes. Ethn Dis. 2003;13:369–74.

    PubMed  Google Scholar 

  37. Jiang HJ, Andrews R, Stryer D, Friedman B. Racial/ethnic disparities in potentially preventable readmissions: the case of diabetes. Am J Public Health. 2005;95(9):1561–7.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Seyoum B, Berhanu P. Profile of diabetic ketoacidosis in a predominatly African American urban patient population. Ethn Dis. 2007;17:234–7.

    PubMed  Google Scholar 

  39. Kim H, Ross JS, Melkus GD, Zhao Z, Boockvar K. Scheduled and unscheduled hospital readmissions among diabetes patients. Am J Manag Care. 2010;16(10):760–7.

    PubMed  PubMed Central  Google Scholar 

  40. Randall L, Begovic J, Hudson M, Smiley D, Peng L, Pitre N, et al. Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors. Diabetes Care. 2011;34(9):1891–6.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Ma Z, Fisher MA. Characteristics driving higher diabetes-related hospital charges in Pennsylvania. Am J Manag Care. 2014;20(9):e408–e17.

    PubMed  Google Scholar 

  42. Bradford AL, Crider CC, Xu X, Naqvi SH. Predictors of recurrent hospital admission for patients presenting with diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Med Res. 2017;9(1):35–9.

    Article  PubMed  Google Scholar 

  43. Tung EL, Baig AA, Huang ES, Laiteerapong N, Chua KP. Racial and ethnic disparities in diabetes screening between Asian Americans and other adults: BRFSS 2012-2014. J Gen Intern Med. 2017;32(4):423–9.

    Article  PubMed  Google Scholar 

  44. Siu AL. Force USPST. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2015;163(11):861–8.

    Article  PubMed  Google Scholar 

  45. Reducing Racial/Ethnic Disparities in Access to Care. Available from: https://www.commonwealthfund.org/publications/issue-briefs/2017/aug/reducing-racial-and-ethnic-disparities-access-care-has. Accessed June 2020.

  46. Tseng E, Greer RC, O'Rourke P, Yeh HC, McGuire MM, Clark JM, et al. Survey of primary care providers' knowledge of screening for, diagnosing and managing prediabetes. J Gen Intern Med. 2017;32(11):1172–8.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.

    Article  CAS  PubMed  Google Scholar 

  48. Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, et al. The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care. 2003;26(12):3230–6.

    Article  PubMed  Google Scholar 

  49. Sakane N, Sato J, Tsushita K, Tsujii S, Kotani K, Tsuzaki K, et al. Prevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance. BMC Public Health. 2011;11(1):40.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49(2):289–97.

    Article  CAS  PubMed  Google Scholar 

  51. Haw JS, Galaviz KI, Straus AN, Kowalski AJ, Magee MJ, Weber MB, et al. Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med. 2017;177(12):1808–17.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Tabak RG, Sinclair KA, Baumann AA, Racette SB, Sebert Kuhlmann A, Johnson-Jennings MD, et al. A review of diabetes prevention program translations: use of cultural adaptation and implementation research. Transl Behav Med. 2015;5(4):401–14.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Sattin RW, Williams LB, Dias J, Garvin JT, Marion L, Joshua TV, et al. Community trial of a faith-based lifestyle intervention to prevent diabetes among African-Americans. J Community Health. 2016;41(1):87–96.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Ali MK, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff. 2012;31(1):67–75.

    Article  Google Scholar 

  55. Shah M, Kaselitz E, Heisler M. The role of community health workers in diabetes: update on current literature. Curr Diab Rep. 2013;13(2):163–71.

    Article  PubMed  PubMed Central  Google Scholar 

  56. O'Brien MJ, Perez A, Scanlan AB, Alos VA, Whitaker RC, Foster GD, et al. PREVENT-DM comparative effectiveness trial of lifestyle intervention and metformin. Am J Prev Med. 2017;52(6):788–97.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Albright AL, Gregg EW. Preventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program. Am J Prev Med. 2013;44(4 Suppl 4):S346–51.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Attridge M, Creamer J, Ramsden M, Cannings-John R, Hawthorne K. Culturally appropriate health education for people in ethnic minority groups with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2014;9:CD006424.

    Google Scholar 

  59. Creamer J, Attridge M, Ramsden M, Cannings-John R, Hawthorne K. Culturally appropriate health education for type 2 diabetes in ethnic minority groups: an updated Cochrane Review of randomized controlled trials. Diabet Med. 2016;33(2):169–83.

    Article  CAS  PubMed  Google Scholar 

  60. Smalls BL, Walker RJ, Bonilha HS, Campbell JA, Egede LE. Community interventions to improve glycemic control in African Americans with type 2 diabetes: a systemic review. Global J Health Sci. 2015;7(5):171–82.

    Article  Google Scholar 

  61. Schmittdiel JA, Gopalan A, Lin MW, Banerjee S, Chau CV, Adams AS. Population health management for diabetes: health care system-level approaches for improving quality and addressing disparities. Curr Diab Rep. 2017;17(5):31.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Ali MK, Wharam F, Kenrik Duru O, Schmittdiel J, Ackermann RT, Albu J, et al. Advancing health policy and program research in diabetes: findings from the Natural Experiments for Translation in Diabetes (NEXT-D) Network. Curr Diab Rep. 2018;18(12):146.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Walker RJ, Smalls BL, Campbell JA, Strom Williams JL, Egede LE. Impact of social determinants of health on outcomes for type 2 diabetes: a systematic review. Endocrine. 2014;47(1):29–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. LaVeist TA, Thorpe RJ Jr, Galarraga JE, Bower KM, Gary-Webb TL. Environmental and socio-economic factors as contributors to racial disparities in diabetes prevalence. J Gen Intern Med. 2009;24(10):1144–8.

    Article  PubMed  PubMed Central  Google Scholar 

  65. LaVeist T, Pollack K, Thorpe R Jr, Fesahazion R, Gaskin D. Place, not race: disparities dissipate in Southwest Baltimore when blacks and whites live under similar conditions. Health Aff. 2011;30(10):1880–7.

    Article  Google Scholar 

  66. Walker RJ, Strom Williams J, Egede LE. Influence of race, ethnicity and social determinants of health on diabetes outcomes. Am J Med Sci. 2016;351(4):366–73.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Matsushita K, Tang O, Selvin E. Addressing challenges and implications of national surveillance for racial/ethnic disparities in diabetes. JAMA. 2019;322(24):2387–8.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Ng JH, Ward LM, Shea M, Hart L, Guerino P, Scholle SH. Explaining the relationship between minority group status and health disparities: a review of selected concepts. Health Equity. 2019;3(1):47–60.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Smalls BL, Gregory CM, Zoller JS, Egede LE. Direct and indirect effects of neighborhood factors and self-care on glycemic control in adults with type 2 diabetes. J Diabetes Complicat. 2015;29(2):186–91.

    Article  Google Scholar 

  70. Arya S, Binney Z, Khakharia A, Brewster LP, Goodney P, Patzer R, et al. Race and socioeconomic status independently affect risk of major amputation in peripheral artery disease. J Am Heart Assoc. 2018;7(2):e007425. https://doi.org/10.1161/JAHA.117.007425.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Sonya Haw.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Diabetes Epidemiology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Haw, J.S., Shah, M., Turbow, S. et al. Diabetes Complications in Racial and Ethnic Minority Populations in the USA. Curr Diab Rep 21, 2 (2021). https://doi.org/10.1007/s11892-020-01369-x

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11892-020-01369-x

Keywords

Navigation